GlaxoSmithKline’s Egyptian acquisition
GlaxoSmithKline (GSK) has agreed to acquire the Egyptian mature products business of Bristol-Myers Squibb for US$210 million (£125 million).
News
GlaxoSmithKline (GSK) has agreed to acquire the Egyptian mature products business of Bristol-Myers Squibb for US$210 million (£125 million).
News
News